Isaac Cebrecos - Publications

SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytes.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 15, 2026

Erratum to "Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study": [ESMO Open 9 (2024) 103989].

Journal: ESMO open

Published: January 06, 2026

SUMMARY: Selective Sentinel Lymph Node Biopsy (SSLNB) in breast cancer for residents.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: August 04, 2025

Case Report: Personalized management of HER2-positive breast cancer with advanced nodal disease during pregnancy: a clinical case and review.

Journal: Frontiers in oncology

Published: July 24, 2025

Second-Look Ultrasound: When Things Are Not Always as They Seem.

Journal: Ultrasound quarterly

Published: May 14, 2025

Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer.

Journal: ESMO open

Published: April 28, 2025

Selective sentinel lymph node biopsy in breast cancer local recurrence.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: April 26, 2025

Preoperative Radiation Therapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results From the YOUNGSTER trial.

Journal: International journal of radiation oncology, biology, physics

Published: January 30, 2025

Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review.

Journal: Breast (Edinburgh, Scotland)

Published: November 29, 2024

Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes.

Journal: Cancers

Published: September 15, 2024

Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice.

Journal: Breast cancer research and treatment

Published: August 14, 2024

Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 30, 2024